Nuvation Bio CFO Fox to step down

Nuvation Bio announced that Jennifer Fox will be stepping down from her role as Chief Financial Officer to pursue a new opportunity. Fox has advised the company that she is seeking later stage development and commercial launch experience as part of her career development and that she is leaving with a high regard for the company, its leadership and its financial state. Fox submitted her resignation on November 9, 2023 with an effective date of November 27, 2023. Members of the executive management team and the company’s finance team will assume the duties and responsibilities of the CFO office. “Jen has played an integral role in helping to set the strategic and financial direction for Nuvation Bio, and I want to thank her for her dedication and hard work in moving Nuvation Bio forward,” said David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio. “We owe her a great deal of gratitude for her contributions and wish her all the best in her future endeavors.”